Literature DB >> 17015669

Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains.

R A Stabler1, D N Gerding, J G Songer, D Drudy, J S Brazier, H T Trinh, A A Witney, J Hinds, B W Wren.   

Abstract

Clostridium difficile is the most frequent cause of nosocomial diarrhea worldwide, and recent reports suggested the emergence of a hypervirulent strain in North America and Europe. In this study, we applied comparative phylogenomics (whole-genome comparisons using DNA microarrays combined with Bayesian phylogenies) to model the phylogeny of C. difficile, including 75 diverse isolates comprising hypervirulent, toxin-variable, and animal strains. The analysis identified four distinct statistically supported clusters comprising a hypervirulent clade, a toxin A(-) B(+) clade, and two clades with human and animal isolates. Genetic differences among clades revealed several genetic islands relating to virulence and niche adaptation, including antibiotic resistance, motility, adhesion, and enteric metabolism. Only 19.7% of genes were shared by all strains, confirming that this enteric species readily undergoes genetic exchange. This study has provided insight into the possible origins of C. difficile and its evolution that may have implications in disease control strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015669      PMCID: PMC1636221          DOI: 10.1128/JB.00664-06

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  31 in total

1.  A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins.

Authors:  E Chaves-Olarte; P Löw; E Freer; T Norlin; M Weidmann; C von Eichel-Streiber; M Thelestam
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

Review 2.  Clostridium difficile--associated diarrhea.

Authors:  S Johnson; D N Gerding
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

3.  Investigation of an outbreak of antibiotic-associated colitis by various typing methods.

Authors:  J Wüst; N M Sullivan; U Hardegger; T D Wilkins
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

4.  Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems.

Authors:  C R Clabots; S Johnson; K M Bettin; P A Mathie; M E Mulligan; D R Schaberg; L R Peterson; D N Gerding
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

5.  An H(+)-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa.

Authors:  Gui-Xin He; Teruo Kuroda; Takehiko Mima; Yuji Morita; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

6.  Evidence to support the existence of subgroups within the UK epidemic Clostridium difficile strain (PCR ribotype 1).

Authors:  W N Fawley; J Freeman; M H Wilcox
Journal:  J Hosp Infect       Date:  2003-05       Impact factor: 3.926

7.  Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types.

Authors:  Ludovic Lemee; Anne Dhalluin; Martine Pestel-Caron; Jean-François Lemeland; Jean-Louis Pons
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

8.  Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile.

Authors:  Masahiro Toyokawa; Akiko Ueda; Hisako Tsukamoto; Isao Nishi; Masayuki Horikawa; Atsuko Sunada; Seishi Asari
Journal:  J Infect Chemother       Date:  2003-12       Impact factor: 2.211

9.  Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis.

Authors:  Stewart J Hinchliffe; Karen E Isherwood; Richard A Stabler; Michael B Prentice; Alexander Rakin; Richard A Nichols; Petra C F Oyston; Jason Hinds; Richard W Titball; Brendan W Wren
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

10.  A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

Authors:  M Rupnik; V Avesani; M Janc; C von Eichel-Streiber; M Delmée
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more
  107 in total

1.  Integration of metabolism and virulence by Clostridium difficile CodY.

Authors:  Sean S Dineen; Shonna M McBride; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

2.  Clostridium difficile genotypes in piglet populations in Germany.

Authors:  Alexander Schneeberg; Heinrich Neubauer; Gernot Schmoock; Sylvia Baier; Jürgen Harlizius; Hendrik Nienhoff; Katja Brase; Stefan Zimmermann; Christian Seyboldt
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

3.  Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.

Authors:  P Pancholi; C Kelly; M Raczkowski; J M Balada-Llasat
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

4.  Expanding the diagnostic capabilities of molecular microbiology by genomic methods.

Authors:  Wenyong W Zhang; James Versalovic
Journal:  J Mol Diagn       Date:  2007-09-14       Impact factor: 5.568

5.  Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs?

Authors:  Abraham Goorhuis; Sylvia B Debast; Leo A M G van Leengoed; Celine Harmanus; Daan W Notermans; Aldert A Bergwerff; Edward J Kuijper
Journal:  J Clin Microbiol       Date:  2008-03       Impact factor: 5.948

6.  Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China.

Authors:  Pengcheng Du; Bo Cao; Jing Wang; Wenge Li; Hongbing Jia; Wen Zhang; Jinxing Lu; Zhongjie Li; Hongjie Yu; Chen Chen; Ying Cheng
Journal:  J Clin Microbiol       Date:  2014-06-23       Impact factor: 5.948

7.  Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.

Authors:  Trevor D Lawley; Simon Clare; Alan W Walker; David Goulding; Richard A Stabler; Nicholas Croucher; Piero Mastroeni; Paul Scott; Claire Raisen; Lynda Mottram; Neil F Fairweather; Brendan W Wren; Julian Parkhill; Gordon Dougan
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 8.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

9.  The A, B, BI, and Cs of Clostridium difficile.

Authors:  Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

10.  Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.

Authors:  Ruth Murray; Dave Boyd; Paul N Levett; Michael R Mulvey; Michelle J Alfa
Journal:  BMC Infect Dis       Date:  2009-06-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.